GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Igf1 | affects expression | ISO | Igf1 (Mus musculus) | 6480464 | CTD | Benzo(a)pyrene affects the expression of IGF1 mRNA | PMID:15037607 | Igf1 | affects methylation | ISO | IGF1 (Homo sapiens) | 6480464 | CTD | Benzo(a)pyrene affects the methylation of IGF1 5' UTR | PMID:27901495 | Igf1 | decreases expression | ISO | Igf1 (Mus musculus) | 6480464 | CTD | Benzo(a)pyrene results in decreased expression of IGF1 mRNA | PMID:15034205 PMID:19770486 PMID:21569818 | Igf1 | decreases expression | ISO | IGF1 (Homo sapiens) | 6480464 | CTD | Benzo(a)pyrene results in decreased expression of IGF1 mRNA | PMID:32234424 | Igf1 | decreases methylation | ISO | IGF1 (Homo sapiens) | 6480464 | CTD | Benzo(a)pyrene results in decreased methylation of IGF1 3' UTR; Benzo(a)pyrene results in decreased methylation of IGF1 promoter | PMID:27901495 | Igf1 | increases expression | ISO | Igf1 (Mus musculus) | 6480464 | CTD | Benzo(a)pyrene results in increased expression of IGF1 mRNA | PMID:15894712 PMID:22610609 | Igf1 | increases expression | ISO | IGF1 (Homo sapiens) | 6480464 | CTD | Benzo(a)pyrene results in increased expression of IGF1 mRNA | PMID:17879257 | Igf1 | multiple interactions | ISO | Igf1 (Mus musculus) | 6480464 | CTD | [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of IGF1 mRNA; AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of IGF1 mRNA] | PMID:15034205 PMID:15894712 | Igf1 | multiple interactions | ISO | IGF1 (Homo sapiens) | 6480464 | CTD | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGF1 mRNA; [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of IGF1 mRNA; [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of IGF1 mRNA; [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of IGF1 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of IGF1 mRNA; Benzo(a)pyrene inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]; IGF1 protein inhibits the reaction [Benzo(a)pyrene results in decreased phosphorylation of FOXO4 protein]; IGF1 protein inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP1 protein]; IGF1 protein inhibits the reaction [Benzo(a)pyrene results in increased expression of BECN1 protein]; IGF1 protein inhibits the reaction [Benzo(a)pyrene results in increased expression of IL18 protein]; IGF1 protein inhibits the reaction [Benzo(a)pyrene results in increased expression of IL1B protein]; IGF1 protein inhibits the reaction [Benzo(a)pyrene results in increased expression of NOS2 protein]; IGF1 protein inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 protein] | PMID:17690111 PMID:30726812 | |
Go Back to source page | Continue to Ontology report |